LIFE TECHNOLOGIES CORPORATION — Lobbying Disclosure | Poliscope

LIFE TECHNOLOGIES CORPORATION

View full entity profile (contributions, contracts, SEC) →

This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.

Lobbying Spend

$3.6M

Filings

Firms Hired

Active Period

2005–2013

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2013	$390,000	7	2
2012	$655,000	14	3
2011	$700,000	13	4
2010	$940,000	15	4
2009	$940,000	12	3
2008	—	4	1
2007	—	2	1
2006	—	2	1
2005	—	2	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
LIFE TECHNOLOGIES CORPORATION	$3,625,000	22
TIBER CREEK GROUP	—	26
SIDLEY AUSTIN LLP	—	8
CARDINAL POINT PARTNERS	—	10
HOLLAND & KNIGHT LLP	—	5

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	55
SENATE	51
Centers For Medicare and Medicaid Services (CMS)	6
Food & Drug Administration (FDA)	5
Federal Bureau of Investigation (FBI)	2
Health & Human Services, Dept of (HHS)	2
Natl Bioethics Advisory Commission	2
Natl Institutes of Health (NIH)	2
Agriculture, Dept of (USDA)	1
Executive Office of the President (EOP)	1
Homeland Security, Dept of (DHS)	1
Office of Science & Technology Policy (OSTP)	1
Securities & Exchange Commission (SEC)	1
Treasury, Dept of	1

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Copyright/Patent/Trademark	Copyright/Patent/Trademark	35
Science/Technology	Science/Technology	35
Law Enforcement/Crime/Criminal Justice	Law Enforcement/Crime/Criminal Justice	30
Budget/Appropriations	Budget/Appropriations	30
Health Issues	Health Issues	20
Taxation/Internal Revenue Code	Taxation/Internal Revenue Code	18
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	16
Homeland Security	Homeland Security	13
Food Industry (safety, labeling, etc.)	Food Industry (safety, labeling, etc.)	8
Financial Institutions/Investments/Securities	Financial Institutions/Investments/Securities	7
Agriculture	Agriculture	6
Medicare/Medicaid	Medicare/Medicaid	6
Immigration	Immigration	2
Animals	Animals	1
Accounting	Accounting	1

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 2085113th Congress

Diagnostic Innovation Testing and Knowledge Advancement Act of 2013

2013 · fourth_quarter · Firm: LIFE TECHNOLOGIES CORPORATION

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 3005: Medical Testing Availablity Act of 2013; Provisions regarding FDA regulations of certain diagnostics and lab developed tests. Draft and final guidance regarding commercially distributed in vitro diagnostic products labeled "For Research Only" or "Investigational Use Only"; Provisions regarding FDA regulation of certain diagnostics.H.R. 2085: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013; Provisions regarding value based payment for advanced diagnostics.

Client expense: $50,000 · Firm income: —

Matched citations: H.R. 2085

H.R. 3005113th Congress

Medical Testing Availability Act of 2013

2013 · fourth_quarter · Firm: LIFE TECHNOLOGIES CORPORATION

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 3005: Medical Testing Availablity Act of 2013; Provisions regarding FDA regulations of certain diagnostics and lab developed tests. Draft and final guidance regarding commercially distributed in vitro diagnostic products labeled "For Research Only" or "Investigational Use Only"; Provisions regarding FDA regulation of certain diagnostics.H.R. 2085: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013; Provisions regarding value based payment for advanced diagnostics.

Client expense: $50,000 · Firm income: —

Matched citations: H.R. 3005

S. 1871113th Congress

SGR Repeal and Medicare Beneficiary Access Act of 2013

2013 · fourth_quarter · Firm: LIFE TECHNOLOGIES CORPORATION

Open original LDA filing ↗

Cited source text and reported amounts

Subregulatory: Molecular Pathology Fee Schedules; Provisions regarding Medicare rate settings for certain diagnostics. S. 1871: The SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013; Provisions regarding diagnostic amendments.

Client expense: $50,000 · Firm income: —

Matched citations: S. 1871

H.R. 2085113th Congress

Diagnostic Innovation Testing and Knowledge Advancement Act of 2013

2013 · fourth_quarter · Firm: LIFE TECHNOLOGIES CORPORATION

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 3005: Medical Testing Availablity Act of 2013; Provisions regarding FDA regulations of certain diagnostics and lab developed tests. Draft and final guidance regarding commercially distributed in vitro diagnostic products labeled "For Research Only" or "Investigational Use Only"; Provisions regarding FDA regulation of certain diagnostics.H.R. 2085: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013; Provisions regarding value based payment for advanced diagnostics.

Client expense: $50,000 · Firm income: —

Matched citations: H.R. 2085

Show 21 more cited filings

H.R. 3005113th Congress

Medical Testing Availability Act of 2013

2013 · fourth_quarter · Firm: LIFE TECHNOLOGIES CORPORATION

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 3005: Medical Testing Availablity Act of 2013; Provisions regarding FDA regulations of certain diagnostics and lab developed tests. Draft and final guidance regarding commercially distributed in vitro diagnostic products labeled "For Research Only" or "Investigational Use Only"; Provisions regarding FDA regulation of certain diagnostics.H.R. 2085: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013; Provisions regarding value based payment for advanced diagnostics.

Client expense: $50,000 · Firm income: —

Matched citations: H.R. 3005

S. 1871113th Congress

SGR Repeal and Medicare Beneficiary Access Act of 2013

2013 · fourth_quarter · Firm: LIFE TECHNOLOGIES CORPORATION

Open original LDA filing ↗

Cited source text and reported amounts

Subregulatory: Molecular Pathology Fee Schedules; Provisions regarding Medicare rate settings for certain diagnostics. S. 1871: The SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013; Provisions regarding diagnostic amendments.

Client expense: $50,000 · Firm income: —

Matched citations: S. 1871

H.R. 2085113th Congress

Diagnostic Innovation Testing and Knowledge Advancement Act of 2013

2013 · third_quarter · Firm: LIFE TECHNOLOGIES CORPORATION

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 3005: Medical Testing Availablity Act of 2013; Provisions regarding FDA regulations of certain diagnostics and lab developed tests. Draft guidance regarding commercially distributed in vitro diagnostic products labeled "For Research Only or Investigational Use Only:" Frequently Asked Questions; Provisions regarding regulation of certain diagnostics.H.R. 2085: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013; Provisions regarding value based payment for advanced diagnostics.

Client expense: $70,000 · Firm income: —

Matched citations: H.R. 2085

H.R. 3005113th Congress

Medical Testing Availability Act of 2013

2013 · third_quarter · Firm: LIFE TECHNOLOGIES CORPORATION

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 3005: Medical Testing Availablity Act of 2013; Provisions regarding FDA regulations of certain diagnostics and lab developed tests. Draft guidance regarding commercially distributed in vitro diagnostic products labeled "For Research Only or Investigational Use Only:" Frequently Asked Questions; Provisions regarding regulation of certain diagnostics.H.R. 2085: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013; Provisions regarding value based payment for advanced diagnostics.

Client expense: $70,000 · Firm income: —

Matched citations: H.R. 3005

H.R. 845113th Congress

Saving High-Tech Innovators from Egregious Legal Disputes Act of 2013

2013 · third_quarter · Firm: LIFE TECHNOLOGIES CORPORATION

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 845: Saving High-Tech Innovators from Egregious Legal Disputes Act of 2013 (The SHIELD Act); Provisions regarding patent litigation reform. S. 1013: Patent Abuse Reduction Act of 2013; Provisions regarding patent litigation reform. House and Senate Judiciary Discussion Drafts; Provisions regarding patent litigation reform.

Client expense: $70,000 · Firm income: —

Matched citations: H.R. 845

S. 744111th Congress

Affordable Tutoring of Our Children Act

2013 · third_quarter · Firm: LIFE TECHNOLOGIES CORPORATION

Open original LDA filing ↗

Cited source text and reported amounts

S. 744: Border Security, Economic Opportunity, and Immigration Modernization Act; Provisions regarding DNA amendments.

Client expense: $70,000 · Firm income: —

Matched citations: S. 744

S. 1013113th Congress

Patent Abuse Reduction Act of 2013

2013 · third_quarter · Firm: LIFE TECHNOLOGIES CORPORATION

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 845: Saving High-Tech Innovators from Egregious Legal Disputes Act of 2013 (The SHIELD Act); Provisions regarding patent litigation reform. S. 1013: Patent Abuse Reduction Act of 2013; Provisions regarding patent litigation reform. House and Senate Judiciary Discussion Drafts; Provisions regarding patent litigation reform.

Client expense: $70,000 · Firm income: —

Matched citations: S. 1013

S. 822113th Congress

Justice for All Reauthorization Act of 2013

2013 · third_quarter · Firm: LIFE TECHNOLOGIES CORPORATION

Open original LDA filing ↗

Cited source text and reported amounts

S. 822: Justice for All Reauthorizatio Act of 2013: Provisions regarding Debbie Smith DNA backlog.

Client expense: $70,000 · Firm income: —

Matched citations: S. 822

H.R. 6628112th Congress

SAFER Act of 2012

2013 · second_quarter · Firm: LIFE TECHNOLOGIES CORPORATION

Open original LDA filing ↗

Cited source text and reported amounts

HR 6628/S. 3250: Sexual Assault Forensic Evidence Registry (SAFER) Act; Provisions regarding DNA testing.

Client expense: $120,000 · Firm income: —

Matched citations: HR 6628

S. 3250111th Congress

Federal Buildings Personnel Training Act of 2010

2013 · second_quarter · Firm: LIFE TECHNOLOGIES CORPORATION

Open original LDA filing ↗

Cited source text and reported amounts

HR 6628/S. 3250: Sexual Assault Forensic Evidence Registry (SAFER) Act; Provisions regarding DNA testing.

Client expense: $120,000 · Firm income: —

Matched citations: S. 3250

S. 744111th Congress

Affordable Tutoring of Our Children Act

2013 · second_quarter · Firm: LIFE TECHNOLOGIES CORPORATION

Open original LDA filing ↗

Cited source text and reported amounts

S. 744: Border Security, Economic Opportunity, and Immigration Modernization Act; Provisions regarding DNA amendments.

Client expense: $120,000 · Firm income: —

Matched citations: S. 744

H.R. 6628112th Congress

SAFER Act of 2012

2013 · first_quarter · Firm: LIFE TECHNOLOGIES CORPORATION

Open original LDA filing ↗

Cited source text and reported amounts

HR 6628/S. 3250: Sexual Assault Forensic Evidence Registry (SAFER) Act; Provisions regarding DNA testing.

Client expense: $100,000 · Firm income: —

Matched citations: HR 6628

S. 3250111th Congress

Federal Buildings Personnel Training Act of 2010

2013 · first_quarter · Firm: LIFE TECHNOLOGIES CORPORATION

Open original LDA filing ↗

Cited source text and reported amounts

HR 6628/S. 3250: Sexual Assault Forensic Evidence Registry (SAFER) Act; Provisions regarding DNA testing.

Client expense: $100,000 · Firm income: —

Matched citations: S. 3250

H.R. 6014112th Congress

Katie Sepich Enhanced DNA Collection Act of 2012

2012 · fourth_quarter · Firm: TIBER CREEK GROUP

Open original LDA filing ↗

Cited source text and reported amounts

DNA testing in general. H.R. 988/S. 517, the Katie Sepich Enhanced DNA Collection Act of 2011. H.R. 6014/ S. 250, Katie Sepich Enhanced DNA Collection Act of 2012, Title II.

Client expense: — · Firm income: $20,000

Matched citations: H.R. 6014

H.R. 6014112th Congress

Katie Sepich Enhanced DNA Collection Act of 2012

2012 · fourth_quarter · Firm: TIBER CREEK GROUP

Open original LDA filing ↗

Cited source text and reported amounts

DNA testing in general. H.R. 988/S. 517, Katie Sepich Enhanced DNA Collection Act of 2011. Laboratory testing in general. FDA regulations in general. NIH funding in general and effect of sequestration. H.R. 6014/ S. 250, Katie Sepich Enhanced DNA Collection Act of 2012, Title II.

Client expense: — · Firm income: $20,000

Matched citations: H.R. 6014

H.R. 988112th Congress

Katie Sepich Enhanced DNA Collection Act of 2011

2012 · fourth_quarter · Firm: TIBER CREEK GROUP

Open original LDA filing ↗

Cited source text and reported amounts

DNA testing in general. H.R. 988/S. 517, the Katie Sepich Enhanced DNA Collection Act of 2011. H.R. 6014/ S. 250, Katie Sepich Enhanced DNA Collection Act of 2012, Title II.

Client expense: — · Firm income: $20,000

Matched citations: H.R. 988

H.R. 988112th Congress

Katie Sepich Enhanced DNA Collection Act of 2011

2012 · fourth_quarter · Firm: TIBER CREEK GROUP

Open original LDA filing ↗

Cited source text and reported amounts

DNA testing in general. H.R. 988/S. 517, Katie Sepich Enhanced DNA Collection Act of 2011. Laboratory testing in general. FDA regulations in general. NIH funding in general and effect of sequestration. H.R. 6014/ S. 250, Katie Sepich Enhanced DNA Collection Act of 2012, Title II.

Client expense: — · Firm income: $20,000

Matched citations: H.R. 988

H.R. 3207112th Congress

Modernizing Laboratory Test Standards for Patients Act of 2011

2012 · fourth_quarter · Firm: LIFE TECHNOLOGIES CORPORATION

Open original LDA filing ↗

Cited source text and reported amounts

Draft guidance regarding Commercially Distributed In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Frequently Asked Questions; Provisions regarding FDA regulation of certain diagnostics. H.R. 3207: Modernizing Laboratory Test Standards for Patients Act of 2011; Provisions regarding lab developed tests. Draft regulation regarding Unique Device Identification System: Provisions regarding FDA requirements for medical device labeling.

Client expense: $150,000 · Firm income: —

Matched citations: H.R. 3207

H.R. 6014112th Congress

Katie Sepich Enhanced DNA Collection Act of 2012

2012 · fourth_quarter · Firm: LIFE TECHNOLOGIES CORPORATION

Open original LDA filing ↗

Cited source text and reported amounts

H.R.6014/S.517/S. 250: Katie Sepich Enhanced DNA Collection Act of 2012 and Justice for All Reauthorization Act of 2012; All provisions of the bills; Katie Sepich Act amendment to S. 250. H.R. 6628/S. 3250: Sexual Assault Forensic Evidence Registry (SAFER) Act of 2012; Provisions regarding DNA testing.

Client expense: $150,000 · Firm income: —

Matched citations: H.R.6014

H.R. 6628112th Congress

SAFER Act of 2012

2012 · fourth_quarter · Firm: LIFE TECHNOLOGIES CORPORATION

Open original LDA filing ↗

Cited source text and reported amounts

H.R.6014/S.517/S. 250: Katie Sepich Enhanced DNA Collection Act of 2012 and Justice for All Reauthorization Act of 2012; All provisions of the bills; Katie Sepich Act amendment to S. 250. H.R. 6628/S. 3250: Sexual Assault Forensic Evidence Registry (SAFER) Act of 2012; Provisions regarding DNA testing.

Client expense: $150,000 · Firm income: —

Matched citations: H.R. 6628

H.R. 6014112th Congress

Katie Sepich Enhanced DNA Collection Act of 2012

2012 · third_quarter · Firm: TIBER CREEK GROUP

Open original LDA filing ↗

Cited source text and reported amounts

DNA testing in general. H.R. 988/S. 517, Katie Sepich Enhanced DNA Collection Act of 2011. Laboratory testing in general. FDA regulations in general. NIH funding in general and effect of sequestration. H.R. 6014/ S. 250, Katie Sepich Enhanced DNA Collection Act of 2012, Title II.

Client expense: — · Firm income: $20,000

Matched citations: H.R. 6014

Source: Senate LDA